The US-based Consumer Technology Association (CTA) has developed the first ever accredited standard for use of artificial intelligence in health care, with input from tech giants such as Am
As Biogen prepares for an FDA review of its amyloid-targeting Alzheimer’s drug aducanumab, Roche and Eli Lilly lifted the lid on yet another trial failure involving two drugs aimed at this
